The anti-apoptotic gene BCL2A1 is a novel transcriptional target of PU.1

Leukemia

Volumn 24, Issue 5, 2010, Pages 1073-1076

  Jenal, M ^a   Batliner, J ^a   Reddy, V A ^b   Haferlach, T ^c   Tobler, A ^a,d   Fey, M F ^a,d   Torbett, B E ^e   Tschan, M P ^a,d  

^a UNIVERSITY OF BERN   (Switzerland)

^b Novartis Institute of Functional Genomics   (United States)

^c MLL MUNICH LEUKEMIA LABORATORY   (Germany)

^d UNIVERSITY OF BERN   (Switzerland)

^e SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCL2 RELATED PROTEIN A1; MESSENGER RNA; RETINOIC ACID; TRANSCRIPTION FACTOR PU 1;

ACUTE GRANULOCYTIC LEUKEMIA; ANTINEOPLASTIC ACTIVITY; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LETTER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN PROTEIN INTERACTION;

EID: 77952430252     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2010.26     Document Type: Letter

References (19)

1. Anderson KL, Nelson SL, Perkin HB, Smith KA, Klemsz MJ, Torbett BE. PU.1 is a lineage-specific regulator of tyrosine phosphatase CD45. J Biol Chem 2001; 276: 7637-7642.
2. Rosenbauer F, Tenen DG. Transcription factors in myeloid development: balancing differentiation with transformation. Nat Rev Immunol 2007; 7: 105-117.
3. Tenen DG. Disruption of differentiation in human cancer: AML shows the way. Nat Rev Cancer 2003; 3: 89-101.
4. Youle RJ, Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 2008; 9: 47-59.
5. Sevilla L, Zaldumbide A, Carlotti F, Dayem MA, Pognonec P, Boulukos KE. Bcl-XL expression correlates with primary macro-phage differentiation, activation of functional competence, and survival and results from synergistic transcriptional activation by Ets2 and PU.1. J Biol Chem 2001; 276: 17800-17807.
6. Hamasaki A, Sendo F, Nakayama K, Ishida N, Negishi I, Hatakeyama S. Accelerated neutrophil apoptosis in mice lacking A1-a, a subtype of the bcl-2-related A1 gene. J Exp Med 1998; 188: 1985-1992.
7. Zhao M, Duan XF, Wen DH, Chen GQ. PU.1, a novel caspase-3 substrate, partially contributes to chemotherapeutic agents-induced apoptosis in leukemic cells. Biochem Biophys Res Commun 2009; 382: 508-513.
8. Ueno S, Tatetsu H, Hata H, Iino T, Niiro H, Akashi K et al. PU 1 induces apoptosis in myeloma cells through direct transactivation of TRAIL. Oncogene 2009; 28: 4116-4125.
9. Altucci L, Rossin A, Raffelsberger W, Reitmair A, Chomienne C, Gronemeyer H. Retinoic acid-induced apoptosis in leukemia cells is mediated by paracrine action of tumor-selective death ligand TRAIL. Nat Med 2001; 7: 680-686.
10. Okuno Y, Huang G, Rosenbauer F, Evans EK, Radomska HS, Iwasaki H et al. Potential autoregulation of transcription factor PU 1 by an upstream regulatory element. Mol Cell Biol 2005; 25: 2832-2845.
11. Zong WX, Edelstein LC, Chen C, Bash J, Gelinas C. The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappaB that blocks TNFalpha-induced apoptosis. Genes Dev 1999; 13: 382-387.
12. Yin W, Raffelsberger W, Gronemeyer H. Retinoic acid determines life span of leukemic cells by inducing antagonistic apoptosis-regulatory programs. Int J Biochem Cell Biol 2005; 37: 1696-1708.
13. Mueller BU, Pabst T, Fos J, Petkovic V, Fey MF, Asou N et al. ATRA resolves the differentiation block in t(15;17) acute myeloid leukemia by restoring PU.1 expression. Blood 2006; 107: 3330-3338.
14. Lin EY, Orlofsky A, Berger MS, Prystowsky MB. Characterization of A1, a novel hemopoietic-specific early-response gene with sequence similarity to bcl-2. J Immunol 1993; 151: 1979-1988.
15. Liu CY, Chuang PI, Chou CL, Lin SM, Chen HC, Chou P et al. Cytoprotective response of A1, a Bcl-2 homologue expressed in mature human neutrophils and promyelocytic HL-60 cells, to oxidant stress-induced cell death. J Biomed Sci 2004; 11: 214-227.
16. Sevilla L, Aperlo C, Dulic V, Chambard JC, Boutonnet C, Pasquier O et al. The Ets2 transcription factor inhibits apoptosis induced by colony-stimulating factor 1 deprivation of macrophages through a Bcl-xL-dependent mechanism. Mol Cell Biol 1999; 19: 2624-2634.
17. Xia L, Wurmbach E, Waxman S, Jing Y. Upregulation of Bfl-1/A1 in leukemia cells undergoing differentiation by all-trans retinoic acid treatment attenuates chemotherapeutic agent-induced apoptosis. Leukemia 2006; 20: 1009-1016.
18. Rimmele P, Kosmider O, Mayeux P, Moreau-Gachelin F, Guillouf C. Spi-1/PU.1 participates in erythroleukemogenesis by inhibiting apoptosis in cooperation with Epo signaling and by blocking erythroid differentiation. Blood 2007; 109: 3007-3014.
19. Tschan MP, Reddy VA, Ress A, Arvidsson G, Fey MF, Torbett BE. PU 1 binding to the p53 family of tumor suppressors impairs their transcriptional activity. Oncogene 2008; 27: 3489-3493.